Sanofi (SNYNF) Debt to Equity (2009 - 2025)
Sanofi's (SNYNF) quarterly Debt to Equity came in at $0.26 in Q4 2025, up 26.17% year-on-year from $0.21 in Q4 2024, and down 10.75% quarter-over-quarter from $0.29 in Q2 2025.
Sanofi (SNYNF) Debt to Equity (2009 - 2025) Analysis & Trends
Sanofi has disclosed Debt to Equity across 17 years of filings, most recently posting $0.26 for Q4 2025.
- Debt to Equity for Q4 2025 came in at $0.26, up 26.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.26 (up 26.17% YoY), and the FY2025 annual result was $0.26, up 26.17% from the prior year.
- Debt to Equity came in at $0.26 for Q4 2025 at Sanofi, down from $0.29 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.32 in Q2 2021 to a low of $0.21 in Q4 2024.
- The 5-year median for Debt to Equity is $0.26 (2022), against an average of $0.27.
- Across the five-year window, Debt to Equity decreased 17.12% in 2021 and increased 26.17% in 2025, its largest moves.
- Sanofi's Debt to Equity stood at $0.3 in 2021, then declined by 13.93% to $0.25 in 2022, then declined by 13.0% to $0.22 in 2023, then decreased by 6.76% to $0.21 in 2024, then increased by 26.17% to $0.26 in 2025.
- The last three Debt to Equity figures came in at $0.26 (Q4 2025), $0.29 (Q2 2025), and $0.21 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | 1.39 |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 0.68 |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | -9.70 |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | 0.72 |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | 2.22 |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.26 |
| Jun 30, 2025 | 0.29 |
| Dec 31, 2024 | 0.21 |
| Jun 30, 2024 | 0.30 |
| Dec 31, 2023 | 0.22 |
| Jun 30, 2023 | 0.26 |
| Dec 31, 2022 | 0.25 |
| Jun 30, 2022 | 0.27 |
| Dec 31, 2021 | 0.30 |
| Jun 30, 2021 | 0.32 |
| Dec 31, 2020 | 0.36 |
| Jun 30, 2020 | 0.37 |
| Dec 31, 2019 | 24.25 |
| Jun 30, 2019 | 0.45 |
| Dec 31, 2018 | 0.42 |
| Mar 31, 2018 | 0.46 |
| Dec 31, 2017 | 0.27 |
| Jun 30, 2017 | 0.32 |
| Dec 31, 2016 | 0.32 |
| Dec 31, 2015 | 0.28 |